ABBV - AbbVie Inc.
Close
174.83
0.250 0.143%
Share volume: 105,851
Last Updated: Fri 10 Jan 2025 08:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.49%
PREVIOUS CLOSE
CHG
CHG%
$174.58
0.25
0.14%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-03 | 2023-08-07 | 2023-11-06 | 2024-11-04 | 2024-05-03 | 2024-08-07 | 2024-11-04 | |
| Cash flow financing | -6.192 B | -3.920 B | -2.661 B | -4.449 B | 10.819 B | -6.097 B | -3.072 B | |
| Other financing cash flows | -246.000 M | -282.000 M | -58.000 M | 14.000 M | 127.000 M | 10.000 M | 67.000 M | |
| Cash flow | -2.498 B | 2.058 B | 4.544 B | -496.000 M | 5.271 B | -4.928 B | -5.881 B | |
| Net income | 241.000 M | 2.027 B | 1.781 B | 824.000 M | 1.372 B | 1.373 B | 1.564 B | |
| Depreciation | 179.000 M | 190.000 M | 196.000 M | 187.000 M | 183.000 M | 184.000 M | 191.000 M | |
| Changes in inventories | 185.000 M | 0.000 | 0.000 | 0.000 | 75.000 M | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -499.000 M | -341.000 M | -369.000 M | -800.000 M | -9.588 B | -1.102 B | -8.256 B | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 26.000 M | -1.000 M | 10.000 M | -22.000 M | -6.000 M | -5.000 M | 3.000 M | |
| Dividends Paid | -2.661 B | -2.625 B | -2.627 B | -2.626 B | -2.772 B | -2.750 B | -2.751 B | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 175.000 M | 178.000 M | 219.000 M | 205.000 M | 193.000 M | 241.000 M | 249.000 M | |
| Cash Change | -2.490 B | 2.048 B | 4.528 B | -473.000 M | 5.253 B | -4.937 B | -5.873 B |